(Total Views: 593)
Posted On: 03/18/2021 6:39:13 AM
Post# of 153915
My interpretation, YMMV..
I'd say vastly superior to a kick in the nuts. Would rather have less runway between the announcement and the call, but no biggie.
Quote:
Management will update stockholders on the Company’s recent COVID-19 related filings
[Sounds filed to me, past tense]
for Conditional EUA with the FDA in U.S.,
[Cool, clear as day]
Interim Order in Canada,
[Nice, no confusion there]
and accelerated rolling review in U.K.,
[Sweet, a trifecta]
as well as potential similar filings in Brazil and the Philippines.
[Mm... potential filings, "hopefully". Not surprised about the Philippines though. Curious to see who they're speaking with in Brazil, however]
Management will also provide updates on its active trials in COVID-19,
[Plural? LH is enrolling, CD16 is as well?]
NASH and Cancer,
[Something more to add since last CC?]
along with expected timelines for BLA submissions for HIV in U.S., Canada and U.K.
[God, yes... Not too bad of a turnaround for timeline estimates; have to see what they are and how well they're adhered to]
Management will provide approximately 60 minutes to address questions submitted online by analysts and investors.
I'd say vastly superior to a kick in the nuts. Would rather have less runway between the announcement and the call, but no biggie.
(12)
(0)
